Costa, Sidnei Ferro [UNESP]Gomes, Vinícius Oliveira [UNESP]Maciel, Marilene Oliveira Dos Santos [UNESP]Melo, Larissa Martins [UNESP]Venturin, Gabriela Lovizutto [UNESP]Bragato, Jaqueline Poleto [UNESP]Rebech, Gabriela Torres [UNESP]Santos, Catiule de Oliveirade Oliveira, Bárbara Maria Nascimentode Sá Oliveira, Geraldo Gilenode Lima, Valéria Marçal Felix [UNESP]2020-12-122020-12-122020-01-01PLoS Neglected Tropical Diseases, v. 14, n. 1, p. 1-21, 2020.1935-27351935-2727http://hdl.handle.net/11449/198500Domestic dogs are the main reservoir of Leishmania infantum, a causative agent of visceral leishmaniasis (VL). The number of human disease cases is associated with the rate of canine infection. Currently available drugs are not efficient at treating canine leishmaniasis (CanL) and months after the treatment most dogs show disease relapse, therefore the development of new drugs or new therapeutic strategies should be sought. In CanL, dogs lack the ability to mount a specific cellular immune response suitable for combating the parasite and manipulation of cytokine signaling pathway has the potential to form part of effective immunotherapeutic methods. In this study, recombinant canine cytokines (rcaIL-12, rcaIL-2, rcaIL-15 and rcaIL-7) and soluble receptor IL-10R1 (rcasIL-10R1), with antagonistic activity, were evaluated for the first time in combination (rcaIL-12/rcaIL-2, rcaIL-12/rcaIL-15, rcaIL-12/rcasIL-10R1, rcaIL-15/rcaIL-7) or alone (rcasIL-10R1) to evaluate their immunomodula-tory capacity in peripheral blood mononuclear cells (PBMCs) from dogs with leishmaniasis. All the combinations of recombinant proteins tested were shown to improve lymphoprolifera-tive response. Further, the combinations rcaIL-12/rcaIL-2 and rcaIL-12/rcaIL-15 promoted a decrease in programmed cell death protein 1 (PD-1) expression in lymphocytes. These same combinations of cytokines and rcaIL-12/rcasIL-10R1 induced IFN-γ and TNF-α production in PBMCs. Furthermore, the combination IL-12/IL-15 led to an increased in T-bet expression in lymphocytes. These findings are encouraging and indicate the use of rcaIL-12 and rcaIL-15 in future in vivo studies aimed at achieving polarization of cellular immune responses in dogs with leishmaniasis, which may contribute to the development of an effective treatment against CanL.1-21engArtigo10.1371/journal.pntd.00080212-s2.0-85079204063